This animation has been commissioned by Teva UK Limited and developed in partnership with MGP Ltd. Teva UK Limited suggested the topic for the animation and approved all materials related to the animation. The views and opinions expressed in the animation are not necessarily those of MGP Ltd, its advisers, or advertisers.
Braltus is licensed as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease.1
Watch this short animation to learn about:
- the Zonda inhaler
- potential cost savings for the NHS.
Click here to watch a video on how to use the Braltus® Zonda® inhaler
- Teva UK Limited. Tiotropium (Braltus) 10mcg inhalation powder—summary of product characteristics. June 2016. Available at: www.medicines.org.uk/emc/medicine/32634
Approval code: UK/BRA/17/0009d
Date of preparation: June 2017